Cargando…

Venous thromboembolism associates with SARS-CoV-2 more than seasonal influenza()

Detalles Bibliográficos
Autores principales:	Lachant, Daniel, Roto, Dominick, Rappaport, Stephen, Prasad, Paritosh, Lachant, Neil, White, R. James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253719/ https://www.ncbi.nlm.nih.gov/pubmed/34246012 http://dx.doi.org/10.1016/j.thromres.2021.07.003

Ejemplares similares

Chronic therapeutic anticoagulation is associated with decreased thrombotic complications in SARS‐CoV‐2 infection
por: Lachant, Daniel J., et al.
Publicado: (2020)

Legionella micdadei: A Forgotten Etiology of Growing Cavitary Nodules: A Case Report and Literature Review
por: Lachant, Daniel, et al.
Publicado: (2015)

Direct oral anticoagulant therapy in patients with morbid obesity after intermediate- or high-risk pulmonary emboli
por: Lachant, Daniel J., et al.
Publicado: (2021)

Chronic thromboembolic pulmonary hypertension is a clot you cannot swat
por: Bishop, G. Jay, et al.
Publicado: (2019)

Cardiac Effort to Compare Clinic and Remote 6-Minute Walk Testing in Pulmonary Arterial Hypertension
por: Lachant, Daniel, et al.
Publicado: (2022)

Comparison of chest- and wrist-based actigraphy in pulmonary arterial hypertension
por: Lachant, Daniel, et al.
Publicado: (2021)

Clinical and imaging outcomes after intermediate- or high-risk pulmonary embolus
por: Lachant, Daniel, et al.
Publicado: (2020)

Peak steps: Capacity for activity improves after adding approved therapy in pulmonary arterial hypertension
por: Lachant, Daniel, et al.
Publicado: (2023)

Transitioning selexipag to oral treprostinil in patients with pulmonary artery hypertension
por: Arevalo, Carlo, et al.
Publicado: (2022)

Meningococcemia Presenting as a Myocardial Infarction
por: Lachant, Daniel, et al.
Publicado: (2015)

The clinical impact of pneumocystis and viral PCR testing on bronchoalveolar lavage in immunosuppressed patients()
por: Lachant, Daniel J., et al.
Publicado: (2018)

COVID-19, coagulopathy and venous thromboembolism: more questions than answers
por: Marietta, Marco, et al.
Publicado: (2020)

COVID-19, coagulopathy and venous thromboembolism: more questions than answers—comment
por: Ponzetto, Antonio, et al.
Publicado: (2020)

CMV Encephalitis/Radiculitis: The Difficulty in Diagnosing in an Intubated Patient
por: Newcomb, Geoffrey, et al.
Publicado: (2019)

Asymptomatic necrotizing myositis in a young male with progressive interstitial lung disease
por: Baah, Samantha, et al.
Publicado: (2021)

Acute limb ischemia and aortic mural thrombosis as primary manifestations of severe acute respiratory syndrome coronavirus 2
por: Szeles, Andras, et al.
Publicado: (2021)

Methicillin Resistant Staphylococcus aureus Prostatic Abscess with Bacteremia
por: Lachant, Daniel J., et al.
Publicado: (2013)

Venous Thromboembolism in Denmark: Seasonality in Occurrence and Mortality
por: Skajaa, Nils, et al.
Publicado: (2019)

Heart rate monitoring improves clinical assessment during 6-min walk
por: Lachant, Daniel J., et al.
Publicado: (2020)

Venous thromboembolism in SARS-CoV-2 patients: only a problem in ventilated ICU patients, or is there more to it?
por: Criel, Maarten, et al.
Publicado: (2020)

The epidemiology of venous thromboembolism
por: Heit, John A., et al.
Publicado: (2016)

Heart Rate Expenditure Correlates with Right Ventricular Function
por: Lachant, Daniel J., et al.
Publicado: (2020)

A Fatal Case of Influenza B Myocarditis with Cardiac Tamponade
por: Roto, Dominick, et al.
Publicado: (2018)

Venous thromboembolism frequency in patients hospitalized for SARS-CoV-2 infection
por: Cordeanu, E., et al.
Publicado: (2021)

Venous thromboembolism prophylaxis may cause more harm than benefit: an evidence-based analysis of Canadian and international guidelines
por: Kotaska, Andrew
Publicado: (2018)

Epidemiology and prevention of venous thromboembolism
por: Lutsey, Pamela L., et al.
Publicado: (2022)

SARS-CoV-2 Leads to Significantly More Severe Olfactory Loss than Other Seasonal Cold Viruses
por: Haehner, Antje, et al.
Publicado: (2022)

SARS-CoV-2-induced venous thromboembolism in a patient with VEXAS syndrome
por: Lucchino, Bruno, et al.
Publicado: (2023)

Season of delivery and risk of venous thromboembolism during hospitalization among pregnant women
por: Li, Qian, et al.
Publicado: (2023)

Venous thromboembolism /
por: Hirsh, Jack, 1935-
Publicado: (1981)

SARS-CoV-2 and seasonal influenza: similarities and disparities
por: Dabaja-Younis, Halima, et al.
Publicado: (2022)

Cause-specific death in hospitalized individuals infected with SARS-CoV-2: more than just acute respiratory failure or thromboembolic events
por: Cobos-Siles, Marta, et al.
Publicado: (2020)

Do women with venous thromboembolism bleed more than men during anticoagulation? Data from the real-life, prospective START-Register
por: Palareti, Gualtiero, et al.
Publicado: (2021)

No Difference in Venous Thromboembolism Outcomes after COVID-19 and Influenza Vaccinations
por: Houghton, Damon E., et al.
Publicado: (2022)

Comparison of Venous Thromboembolism Outcomes after COVID-19 and Influenza Vaccinations
por: Gaddh, Manila, et al.
Publicado: (2023)

Respiratory syncytial virus contributes to more severe respiratory morbidity than influenza in children < 2 years during seasonal influenza peaks
por: Amini, Rachid, et al.
Publicado: (2019)

SARS‐CoV‐2 infection and venous thromboembolism after surgery: an international prospective cohort study
Publicado: (2021)

Thalassemia and Venous Thromboembolism
por: Succar, Julien, et al.
Publicado: (2011)

Venous thromboembolism and pregnancy
por: D’Uva, Maristella, et al.
Publicado: (2010)

Neonatal Venous Thromboembolism
por: Haley, Kristina M.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4nfdp3vsucsuf5ja519icu2nk1